<p>On the indicated days, 11 groups of mice (n = 16 per group) were vaccinated with rHA and challenged with infectious PR8 virus.</p>*<p>All mice were bled for sera on the indicated days and all survivors were bled at study conclusion (Blood).</p>**<p>Some mice (n = 1–3) were sacrificed for bronchoalveolar lavage (BAL). Phosphate buffer saline (PBS), AddaVax™ adjuvant (Adj).</p
<p>Immunized mice were challenged with a lethal dose (40 LD<sub>50</sub>) of A/PR8 (<b>A</b> and <b>...
<p>Mice were divided over seven groups and were either vaccinated twice with subunit vaccine with or...
<p>(A–E) Antibody titers elicited by vaccination with DM-C. Six mice per groups were vaccinated with...
<p>(A) Study design: BALB/c mice were vaccinated intranasally with the pressurized H3N8 at the indic...
<p>Survival rates of immunized mice were monitored for 10 days after i.n. infection with mouse adapt...
<p>BALB/c mice were immunized intranasally or sublingually with 1×10<sup>7</sup> PFU or 1×10<sup>8</...
<p>Mice that were administered AF, infected with 1LD<sub>50</sub> of PR/8 virus or immunized with 1,...
<p>BALB/c mice were divided into 3 groups and immunized twice s.c. with 0.1 μg PR8 vaccine or s.l. w...
<p>BALB/c mice were immunized as described above. One week after the booster immunization, mice were...
<p>BALB/c mice were infected with 50 pfu of PR8 virus in 50 µl via the TRT route under penthrane ana...
<p>Six—eight weeks old female BALB/c mice (n = 10 per group) were immunized with 10<sup>10</sup> f88...
<p>BALB/c mice were treated with PR8-specific IgY (anti PR8 IgY) - as described in <a href="http://w...
<p>BALB/c mice (n = 4) were infected with a lethal dose (500 pfu in 50 µl) of PR8 virus via the TRT ...
<p>BALB/c mice were given 500 pfu of PR8 virus in 10 µl by the intranasal route to establish a local...
<p>Mice were (mock-)vaccinated three times either intranasally with BLP-F (○) or PBS (▪) or intramus...
<p>Immunized mice were challenged with a lethal dose (40 LD<sub>50</sub>) of A/PR8 (<b>A</b> and <b>...
<p>Mice were divided over seven groups and were either vaccinated twice with subunit vaccine with or...
<p>(A–E) Antibody titers elicited by vaccination with DM-C. Six mice per groups were vaccinated with...
<p>(A) Study design: BALB/c mice were vaccinated intranasally with the pressurized H3N8 at the indic...
<p>Survival rates of immunized mice were monitored for 10 days after i.n. infection with mouse adapt...
<p>BALB/c mice were immunized intranasally or sublingually with 1×10<sup>7</sup> PFU or 1×10<sup>8</...
<p>Mice that were administered AF, infected with 1LD<sub>50</sub> of PR/8 virus or immunized with 1,...
<p>BALB/c mice were divided into 3 groups and immunized twice s.c. with 0.1 μg PR8 vaccine or s.l. w...
<p>BALB/c mice were immunized as described above. One week after the booster immunization, mice were...
<p>BALB/c mice were infected with 50 pfu of PR8 virus in 50 µl via the TRT route under penthrane ana...
<p>Six—eight weeks old female BALB/c mice (n = 10 per group) were immunized with 10<sup>10</sup> f88...
<p>BALB/c mice were treated with PR8-specific IgY (anti PR8 IgY) - as described in <a href="http://w...
<p>BALB/c mice (n = 4) were infected with a lethal dose (500 pfu in 50 µl) of PR8 virus via the TRT ...
<p>BALB/c mice were given 500 pfu of PR8 virus in 10 µl by the intranasal route to establish a local...
<p>Mice were (mock-)vaccinated three times either intranasally with BLP-F (○) or PBS (▪) or intramus...
<p>Immunized mice were challenged with a lethal dose (40 LD<sub>50</sub>) of A/PR8 (<b>A</b> and <b>...
<p>Mice were divided over seven groups and were either vaccinated twice with subunit vaccine with or...
<p>(A–E) Antibody titers elicited by vaccination with DM-C. Six mice per groups were vaccinated with...